Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 27;13(2):397.
doi: 10.3390/nu13020397.

Influence of Imidazole-Dipeptides on Cognitive Status and Preservation in Elders: A Narrative Review

Affiliations
Review

Influence of Imidazole-Dipeptides on Cognitive Status and Preservation in Elders: A Narrative Review

Nobutaka Masuoka et al. Nutrients. .

Abstract

The worldwide increase in the number of patients with dementia is becoming a growing problem, while Alzheimer's disease (AD), a primary neurodegenerative disorder, accounts for more than 70% of all dementia cases. Research on the prevention or reduction of AD occurrence through food ingredients has been widely conducted. In particular, histidine-containing dipeptides, also known as imidazole dipeptides derived from meat, have received much attention. Imidazole dipeptides are abundant in meats such as poultry, fish, and pork. As evidenced by data from recent human intervention trials conducted worldwide, daily supplementation of carnosine and anserine, which are both imidazole dipeptides, can improve memory loss in the elderly and reduce the risk of developing AD. This article also summarizes the latest researches on the biochemical properties of imidazole dipeptides and their effects on animal models associated with age-related cognitive decline. In this review, we focus on the results of human intervention studies using supplements of poultry-derived imidazole dipeptides, including anserine and carnosine, affecting the preservation of cognitive function in the elderly, and discuss how imidazole dipeptides act in the brain to prevent age-related cognitive decline and the onset of dementia.

Keywords: Alzheimer’s Disease (AD); aging; anserine; carnosine; cognitive function; memory function; mild cognitive impairment (MCI).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The improvement of gloCDR score in ApoE4 + mild cognitive impairment (MCI) patients, who took imidazole dipeptide supplementation for 12 weeks [26]. Average ± SEM are shown in histogram. * p < 0.05.

Similar articles

Cited by

References

    1. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: Clinical characterization and outcome. Arch. Neurol. 1999;56:303–308. doi: 10.1001/archneur.56.3.303. - DOI - PubMed
    1. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 2004;256:183–194. doi: 10.1111/j.1365-2796.2004.01388.x. - DOI - PubMed
    1. Albert M.S., DeKosky S.T., Dickson D., Dubois B., Feldman H.H., Fox N.C., Gamst A., Holtzman D.M., Jagust W.J., Petersen R.C., et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:270–279. doi: 10.1016/j.jalz.2011.03.008. - DOI - PMC - PubMed
    1. Eramudugolla R., Mortby M.E., Sachdev P., Meslin C., Kumar R., Anstey K.J. Evaluation of a research diagnostic algorithm for DSM-5 neurocognitive disorders in a population-based cohort of older adults. Alzheimers Res. Ther. 2017;9:15. doi: 10.1186/s13195-017-0246-x. - DOI - PMC - PubMed
    1. Bredesen D.E., Amos E.C., Canick J., Ackerley M., Raji C., Fiala M., Ahdidan J. Reversal of cognitive decline in Alzheimer’s disease. Aging (Albany NY) 2016;8:1250–1258. doi: 10.18632/aging.100981. - DOI - PMC - PubMed

LinkOut - more resources

  NODES
Association 2
INTERN 1
twitter 2